NASDAQ:ESTA Establishment Labs (ESTA) Stock Price, News & Analysis $67.76 -2.48 (-3.53%) Closing price 04:00 PM EasternExtended Trading$67.78 +0.02 (+0.03%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Establishment Labs Stock (NASDAQ:ESTA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Establishment Labs alerts:Sign Up Key Stats Today's Range$67.09▼$69.9350-Day Range$67.74▼$95.6552-Week Range$37.37▼$97.59Volume319,163 shsAverage Volume523,881 shsMarket Capitalization$2.02 billionP/E RatioN/ADividend YieldN/APrice Target$100.25Consensus RatingModerate Buy Company Overview Establishment Labs Holdings Inc. is a medical technology company focused on developing, manufacturing and commercializing products for breast aesthetics and reconstruction. Founded in 2004 and headquartered in Alajuela, Costa Rica, the company serves plastic surgeons, healthcare providers and patients in markets around the world. Its portfolio is centered on the Motiva line of breast implants, including implants designed for cosmetic augmentation and reconstructive procedures. Establishment Labs also develops related technologies and products, including tissue expanders and surgical systems, as well as Mia Femtech, a minimally invasive breast-enhancement procedure and platform. The company operates internationally through direct sales and distribution partnerships. Establishment Labs was founded by Juan José Chacón-Quesada, who serves as its chief executive officer and has led the company’s development of breast-implant and surgical technologies.AI Generated. May Contain Errors. Read More Establishment Labs Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks58th Percentile Overall ScoreESTA MarketRank™: Establishment Labs scored higher than 58% of companies evaluated by MarketBeat, and ranked 353rd out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingEstablishment Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on no strong buy ratings, 8 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialEstablishment Labs has a consensus price target of $100.25, representing about 47.9% upside from its current price of $67.76.Amount of Analyst CoverageEstablishment Labs has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Establishment Labs' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Establishment Labs are expected to grow in the coming year, from ($1.15) to $0.01 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Establishment Labs is -51.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Establishment Labs is -51.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEstablishment Labs has a P/B Ratio of 83.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Establishment Labs' valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.39% of the float of Establishment Labs has been sold short.Short Interest Ratio / Days to CoverEstablishment Labs has a short interest ratio ("days to cover") of 12.22, which indicates bearish sentiment.Change versus previous monthShort interest in Establishment Labs has recently increased by 7.25%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEstablishment Labs does not currently pay a dividend.Dividend GrowthEstablishment Labs does not have a long track record of dividend growth. News and Social Media3.6 / 5News Sentiment0.72 News SentimentEstablishment Labs has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Establishment Labs this week, compared to 3 articles on an average week.Search Interest2 people have searched for ESTA on MarketBeat in the last 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Establishment Labs insiders have not sold or bought any company stock.Percentage Held by Insiders9.99% of the stock of Establishment Labs is held by insiders.Percentage Held by Institutions72.91% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Establishment Labs' insider trading history. Receive ESTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ESTA Stock News HeadlinesIs Establishment Labs’ (ESTA) Profitability Inflection the Ultimate Buying Opportunity?20 minutes ago | finance.yahoo.comEstablishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic ImplantsSeptember 21 at 9:04 AM | finance.yahoo.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.September 23 at 1:00 AM | Weiss Ratings (Ad)Establishment Labs Holdings Inc. (NASDAQ:ESTA) Given Consensus Recommendation of "Moderate Buy" by BrokeragesSeptember 21 at 2:14 AM | americanbankingnews.comEstablishment Labs: Procedure Economics Strengthens The Bull CaseSeptember 9, 2026 | seekingalpha.comBaron Discovery Fund’s Strategic Trim of Establishment Labs Holdings Inc (ESTA) Locks GainsAugust 12, 2026 | insidermonkey.comEstablishment Labs (ESTA) Stock Looks Fair On Cash Flow Yet Trades At A Premium On SalesAugust 9, 2026 | uk.finance.yahoo.comNeedham Sticks to Their Buy Rating for Establishment Labs Holdings (ESTA)August 8, 2026 | theglobeandmail.comSee More Headlines ESTA Stock Analysis - Frequently Asked Questions How have ESTA shares performed this year? Establishment Labs' stock was trading at $72.88 at the beginning of the year. Since then, ESTA shares have decreased by 7.0% and is now trading at $67.76. How were Establishment Labs' earnings last quarter? Establishment Labs Holdings Inc. (NASDAQ:ESTA) posted its quarterly earnings data on Thursday, August, 6th. The company reported ($0.39) EPS for the quarter, missing analysts' consensus estimates of ($0.34) by $0.05. Establishment Labs's revenue for the quarter was up 31.7% compared to the same quarter last year. Read the conference call transcript. When did Establishment Labs IPO? Establishment Labs (ESTA) raised $59 million in an initial public offering on Thursday, July 19th 2018. The company issued 3,715,277 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager. Who are Establishment Labs' major shareholders? Top institutional investors of Establishment Labs include JW Asset Management LLC (9.04%), BlackRock Inc. (5.38%), William Blair Investment Management LLC (2.40%) and Bank of America Corp DE (2.04%). Insiders that own company stock include Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Raj Denhoy and Raj Denhoy. View institutional ownership trends. How do I buy shares of Establishment Labs? Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Establishment Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Establishment Labs investors own include PayPal (PYPL), NVIDIA (NVDA), Walt Disney (DIS), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD) and Intel (INTC). Company Calendar Last Earnings8/06/2026Today9/23/2026Next Earnings (Estimated)11/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 ESTA's financial health is in the Green zone, according to TradeSmith. ESTA has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:ESTA CIK1688757 Webwww.establishmentlabs.com Phone(062) 434-2400FaxN/AEmployees1,004Year Founded2004Price Target and Rating Average Price Target for Establishment Labs$100.25 High Price Target$117.00 Low Price Target$90.00 Potential Upside/Downside+47.9%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)($1.31) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$51.06 million Net Margins-15.82% Pretax Margin-19.31% Return on Equity-196.69% Return on Assets-10.73% Debt Debt-to-Equity Ratio12.11 Current Ratio3.84 Quick Ratio2.52 Sales & Book Value Annual Sales$211.08 million Price / Sales9.57 Cash FlowN/A Price / Cash FlowN/A Book Value$0.81 per share Price / Book83.65Miscellaneous Outstanding Shares29,800,000Free Float26,825,000Market Cap$2.02 billion OptionableOptionable Beta1.05 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:ESTA) was last updated on 9/23/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
